POCUS Screening for TAA in Hypertensive Patients in the ED

NCT06854588 — Completed, 1483 participants, Chinese University of Hong Kong

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Point-of-care Ultrasound Screening of Thoracic Aortic Aneurysm in Hypertensive Patients in the Emergency Department

RegistryNCT06854588
StatusCompleted
Study typeObservational
Enrollment1483 (Actual)
SponsorChinese University of Hong Kong (Other); collaborators: Hospital Authority, Hong Kong
ConditionsThoracic Aortic Aneurysm (TAA), Aortic Dissection
InterventionsPoint-of-care ultrasound (Diagnostic test)
Datesstart 2025-04-22, primary completion 2026-05-31, completion 2026-07-31, first posted 2025-03-03, last updated 2026-10-21
Locations2 sites in Hong Kong

Related Papers Related Patents Related Grants Related Experts
All trials for Thoracic Aortic Aneurysm (TAA) All trials for Aortic Dissection All trials of Point-of-care ultrasound

-Summary

The investigators are going to recruit hypertensive patients in the emergency department of Prince of Wales Hospital. Point-of-care ultrasound of the aorta and measurements of the aortic diameter will be obtained. Other relevant clinical data will also be obtained for analysis. The primary outcome is the number of patients with a maximum aortic diameter of ≥ 4.5 cm and/or ≥ 50% localized enlarged diameter relative to the adjacent normal segment as indicated by POCUS.

Expand all sections  ·  Collapse all

+Detailed description

Investigators trained with point-of-care ultrasound (POCUS) will recruit hypertensive patients in the emergency department (ED) of Prince of Wales Hospital. POCUS will be performed using a handheld ultrasound device to visualise the aortic root, ascending aorta, aortic arch and descending aorta. Measurements of the diameter will be obtained from different segments of the thoracic aorta for analysis. The definition of aortic aneurysm is a maximum aortic diameter of ≥ 4.5 cm and/or ≥ 50% localized enlarged diameter relative to the adjacent normal segment as indicated by POCUS. The primary outcome is the prevalence of thoracic aortic aneurysm (TAA) in hypertensive patients in the ED. The secondary outcomes include the number of patients with confirmed TAA as verified by CTA, BMI for all participants, the number of CTA scans conducted for TAA confirmation, the number of surgical interventions performed among TAA patients, the ICU admission rate, ICU length of stay, hospital length of stay and mortality, proportion of adequate visualisation of POCUS studies obtained, agreement of aortic diameter measurement between CTA and POCUS, and signs and symptoms of TAA patients presenting to the ED. In addition, the investigators will assess the 28-day all-cause mortality and any advanced imaging done outside the ED.

+Arms and interventions

ArmTypeInterventionsDescription
hypertensive patients presenting to the emergency departmentDiagnostic Test: Point-of-care ultrasound1. Adult patients aged ≥ 18 years attending the ED during the study period 2. Known history of hypertension or newly diagnosed hypertension in the ED
  • Point-of-care ultrasound (Diagnostic test): POCUS screening will be conducted to measure the maximum diameters at end diastole of the aortic root, ascending aorta, aortic arch, and descending thoracic aorta.

+Outcome measures

Primary outcomes

  • number of patients with a dilated aorta [Day 1]: is the number of patients with a maximum aortic diameter of ≥ 4.5 cm and/or ≥ 50% localized enlarged diameter relative to the adjacent normal segment as indicated by POCUS

Secondary outcomes

  • number of patients with confirmed TAA [through study completion, an average of 1 year]: number of patients with confirmed TAA as verified by CTA

Other outcomes

  • BMI for all participants [at the time of recruitment]: BMI in kg/m\^2
  • number of CTA scans [through study completion, an average of 1 year]: number of CTA scans conducted for TAA confirmation
  • number of surgical interventions [from recruitment to 28 days after]: number of surgical interventions performed among TAA patients
  • ICU and hospital length of stay [through study completion, an average of 1 year]: ICU and hospital length of stay among patients with treatment for TAA
  • mortality [from recruitment to 28 days after]: 28-day mortality in both TAA and non-TAA patients
  • proportion of adequate visualisation of POCUS studies obtained [up to 1 year]: proportion of adequate visualisation of POCUS studies (%) obtained during the recruitment period
  • agreement of aortic diameter measurement [from recruitment to 28 days after if CTA is performed]: agreement of aortic diameter measurement between CTA and POCUS in cm

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Adult patients aged ≥ 18 years attending the ED during the study period
* Known history of hypertension or newly diagnosed hypertension in the ED

Exclusion Criteria:

* Known history of aortic aneurysm or dissection
* Previous thoracic aortic interventions or endovascular stenting
* Patients in cardiopulmonary resuscitation
* Traumatic patients
* Patients refuse to participate the study

+Locations (2)

FacilityCityCountryStatus
Prince of Wales HospitalShatin, NTHong Kong
Accident and Emergency Medicine Academic UnitHong KongHong Kong

+Investigators